Atara Biotherapeutics, Inc. (ATRA)

Last Closing Price: 6.34 (2026-11-19)

Gross Profit (Quarterly)

Gross Profit: Revenues from operations less the associated costs.

Atara Biotherapeutics, Inc. (ATRA) had Gross Profit of $0.96M for the most recently reported fiscal quarter, ending 2026-09-30.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
$1.22M
$-2.23M
$0.27M
Gross Profit
$0.96M
$4.19M
$-2.97M
$0.74M
$-2.23M
$-2.23M
$-2.23M
$-2.23M
$-2.23M
$-2.23M
$-2.97M
$-3.01M
15.33M
15.33M
$-0.15
$-0.15
Balance Sheet Financials
$11.31M
$0.04M
$7.29M
$18.61M
$6.57M
--
$49.94M
$56.51M
$-37.90M
$-37.90M
$-37.90M
10.19M
Cash Flow Statement Financials
$-7.29M
$-5.79M
$8.66M
$8.48M
$4.05M
$-4.43M
$1.60M
--
--
Fundamental Metrics & Ratios
1.72
--
--
--
--
78.35%
-242.65%
-242.65%
--
-182.11%
-182.11%
$-7.29M
--
--
--
0.07
--
1.77
50.81
5.88%
5.88%
-11.98%
5.88%
$-3.72
$-0.48
$-0.48